Clinical trial
Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid…
NCT00188136 · University Hospital Carl Gustav Carus, Other · Completed
Key facts
| NCT number | NCT00188136 |
|---|---|
| Title | Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML) |
| Official title | Phase II Study of Early Allogeneic Blood Stem Cell Transplantation During Induction-chemotherapy Induced Aplasia in High-risk Acute Myeloid Leukemia |
| Lead sponsor | University Hospital Carl Gustav Carus, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | Melphalan, ATG, Fludarabine |
| Enrollment | 32 |
| Start date | Aug 1, 2002 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 8, 2015 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: